AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.590
+0.030 (0.84%)
At close: Dec 8, 2025, 4:00 PM EST
3.618
+0.028 (0.79%)
After-hours: Dec 8, 2025, 7:57 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.07 billion as of December 8, 2025. Its market cap has increased by 34.25% in one year.
Market Cap
1.07B
Enterprise Value
721.16M
1-Year Change
34.25%
Ranking
Category
Stock Price
$3.59
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.07B, a decrease of -93.14%. That is a compound annual growth rate of -41.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.07B | 23.13% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
| Dec 11, 2020 | 15.66B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 896.28B |
| Johnson & Johnson | 485.02B |
| AbbVie | 396.71B |
| UnitedHealth Group | 295.74B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 244.18B |
| Abbott Laboratories | 215.17B |